{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:04:01Z","timestamp":1792919041019,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41409-026-02919-9","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:39:15Z","timestamp":1779892755000},"page":"899-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-5328","authenticated-orcid":false,"given":"Raffaella","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5519-9154","authenticated-orcid":false,"given":"Isabel","family":"S\u00e1nchez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-5109","authenticated-orcid":false,"given":"Antonio M.","family":"Risitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5799","authenticated-orcid":false,"given":"Krzysztof","family":"Kalwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-2765","authenticated-orcid":false,"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Kleovoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Atlija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-0097","authenticated-orcid":false,"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6512-6080","authenticated-orcid":false,"given":"Emanuele","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9614-7274","authenticated-orcid":false,"given":"Dina","family":"Averbuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-4997","authenticated-orcid":false,"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ester","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette D.","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-802X","authenticated-orcid":false,"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-483X","authenticated-orcid":false,"given":"Helen","family":"Baldomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-3351","authenticated-orcid":false,"given":"Jakob R.","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1224-091X","authenticated-orcid":false,"given":"Donal P.","family":"McLornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-0123","authenticated-orcid":false,"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-6970","authenticated-orcid":false,"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"2919_CR1","first-page":"197","volume":"8","author":"A Gratwohl","year":"1991","unstructured":"Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transpl. 1991;8:197\u2013201.","journal-title":"Bone Marrow Transpl"},{"issue":"Nov","key":"2919_CR2","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/s41409-025-02701-3","volume":"60","author":"R Greco","year":"2025","unstructured":"Greco R, Ruggeri A, McLornan DP, Snowden JA, Alexander T, Angelucci E, et al. Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations. Bone Marrow Transpl. 2025;60(Nov):1499\u2013525.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41409-018-0153-1","volume":"53","author":"JR Passweg","year":"2018","unstructured":"Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, et al. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transpl. 2018;53:1139\u201348.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2017.34","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. Use of haploidentical stem cell transplantation continues to increase; the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transpl. 2017;52:811\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2010.491","volume":"303","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303:1617\u201324.","journal-title":"JAMA"},{"key":"2919_CR6","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","volume":"2","author":"A Gratwohl","year":"2015","unstructured":"Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, et al. One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol. 2015;2:e91\u2013100.","journal-title":"Lancet Haematol"},{"key":"2919_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bmt.2016.18","volume":"51","author":"D Niederwieser","year":"2016","unstructured":"Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transpl. 2016;51:778\u201385.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3324\/haematol.2009.015586","volume":"95","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D, et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica. 2010;95:637\u201343.","journal-title":"Haematologica"},{"key":"2919_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41409-019-0748-1","volume":"55","author":"NS Majhail","year":"2020","unstructured":"Majhail NS, Mau LW, Chitphakdithai P, Denzen EM, Joffe S, Lee SJ, et al. Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transpl. 2020;55:906\u201317.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41409-020-0826-4","volume":"55","author":"JR Passweg","year":"2020","unstructured":"Passweg JR, Baldomero H, Chabannon C, Basak GW, Corbacioglu S, Duarte R, et al. The EBMT activity survey on hematopoietic cell transplantation and cellular therapy 2018: CAR-T\u2019s come into focus. Bone Marrow Transpl. 2020;55:1604\u201313.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41409-022-01604-x","volume":"57","author":"JR Passweg","year":"2022","unstructured":"Passweg JR, Baldomero H, Chabannon C, Corbacioglu S, de la C\u00e1mara R, Dolstra H, et al. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transpl. 2022;57:742\u201352.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","volume":"58","author":"JR Passweg","year":"2023","unstructured":"Passweg JR, Baldomero H, Ciceri F, Corbacioglu S, de la C\u00e1mara R, Dolstra H, et al. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A report from the EBMT Activity Survey. Bone Marrow Transpl. 2023;58:647\u201358.","journal-title":"Bone Marrow Transpl"},{"issue":"Jun","key":"2919_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41409-024-02248-9","volume":"59","author":"JR Passweg","year":"2024","unstructured":"Passweg JR, Baldomero H, Ciceri F, et al. Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone Marrow Transpl. 2024;59(Jun):803\u201312.","journal-title":"Bone Marrow Transpl"},{"issue":"Apr","key":"2919_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","volume":"60","author":"JR Passweg","year":"2025","unstructured":"Passweg JR, Baldomero H, Altija M, et al. The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT. Bone Marrow Transplant. 2025;60(Apr):519\u201328.","journal-title":"Bone Marrow Transplant"},{"key":"2919_CR15","unstructured":"Sanz J, Ferhat AT, Raiola AM, Blaise D, Arat M, Koc Y, et al. Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT. Bone Marrow Transplant [Internet]. 25 de noviembre de 2025 [citado 6 de febrero de 2026]; Disponible en: https:\/\/www.nature.com\/articles\/s41409-025-02763-3."},{"key":"2919_CR16","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1182\/blood.2023023697","volume":"143","author":"J Sanz","year":"2024","unstructured":"Sanz J, Labopin M, Choi G, Kulagin A, Peccatori J, Vydra J, et al. Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT. Blood. 2024;143:2534\u201343.","journal-title":"Blood"},{"key":"2919_CR17","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/s41375-024-02359-8","volume":"38","author":"S Piemontese","year":"2024","unstructured":"Piemontese S, Labopin M, Choi G, Broers AEC, Peccatori J, Meijer E, et al. Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide. Leukemia. 2024;38:2016\u201322.","journal-title":"Leukemia"},{"key":"2919_CR18","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1182\/bloodadvances.2024013677","volume":"8","author":"RS Mehta","year":"2024","unstructured":"Mehta RS, Petersdorf EW, Wang T, Spellman SR, Lee SJ. Interplay between donor age and HLA-DP matching in 10\/10 HLA-matched unrelated donor HCT. Blood Adv. 2024;8:5438\u201349.","journal-title":"Blood Adv"},{"key":"2919_CR19","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.eclinm.2024.102476","volume":"69","author":"R Greco","year":"2024","unstructured":"Greco R, Alexander T, Del Papa N, M\u00fcller F, Saccardi R, Sanchez-Guijo F, et al. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. eClinicalMedicine. 2024;69:102476.","journal-title":"eClinicalMedicine"},{"key":"2919_CR20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41409-025-02695-y","volume":"60","author":"T Alexander","year":"2025","unstructured":"Alexander T, Roldan E, Del Papa N, Farge D, Henes J, Marjanovic Z, et al. Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee. Bone Marrow Transpl. 2025;60:1451\u201364.","journal-title":"Bone Marrow Transpl"},{"key":"2919_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41582-024-01050-x","volume":"2","author":"PA Muraro","year":"2025","unstructured":"Muraro PA, Mariottini A, Greco R, Burman J, Iacobaeus E, Inglese M, et al. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder \u2014 recommendations from ECTRIMS and the EBMT. Nat Rev Neurol. 2025;2:140\u201358.","journal-title":"Nat Rev Neurol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02919-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02919-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02919-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:59:26Z","timestamp":1783601966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02919-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2919"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02919-9","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RG discloses speaker honoraria for educational events from Biotest, Pfizer, Medac, Qiagen and Kyverna, honoraria for advisory board from Pfizer, BMS, MSD; no-profit organization: EBMT secretary. CoiS non related to this manuscript. TA: Study support from Johnson&Johnson. Honoraria from Abbvie, Amgen, AstraZeneca, GSK and Zenas BioPharma. DA: Speaker MSD, Takeda, not related to this work. OP has no COIs directly related to this work. OP has received honoraria or travel support from Alexion, Gilead, Jazz, MSD, Neovii, Novartis, Pfizer and Therakos. He has received research support from Incyte, Gilead and Priothera. He is member of advisory boards to Apogepha, Alexion, Equillium Bio, Jazz, Gilead, Novartis, MSD, Omeros, Orca Bio, Priothera, Sanofi, Shionogi and SOBI. ISO, AMR, KK, AR, IK, MA, EA, AB, MEB, CC, MH, HB, JP, IYA, DPM, FC and AS: declare no CoI related to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}